AI assistant
MICRO-X LIMITED — Capital/Financing Update 2018
Feb 25, 2018
65388_rns_2018-02-25_e131e624-d1f9-45c4-a116-1f01584c1c22.pdf
Capital/Financing Update
Open in viewerOpens in your device viewer
Micro-X Limited, 1284 South Road, Tonsley, South Australia, 5042
==> picture [127 x 37] intentionally omitted <==
ABN: 21 153 273 735
Monday 26[th] February 2018
ASX Announcement – MICRO-X LIMITED (ASX: MX1)
NANO COMMERCIALISATION UPDATE
Micro-X Limited (‘ Micro-X’ ) is pleased to inform the market of the achievement of one of the most critical milestones in the Nano commercialisation program; Carestream Health Inc. (‘ Carestream’) , Micro-X’s global distribution partner, has now made the DRX Revolution Nano available for sale.
The Product’s brochure, webpages, promotional video and an explanatory White Paper on Carbon NanoTube x-ray technology can be viewed by visiting the relevant page on the Carestream website.
For further information please contact:
Mr Peter Rowland Managing Director, Micro-X Limited Telephone: +61 418 844 981 [email protected] www.micro-x.com
About Micro-X : Micro-X Limited (“ MX1 ”) is an Australian Securities Exchange listed company developing and commercialising a range of highly innovative products based on proprietary carbon nanotube emitter technologies exclusively licensed and sourced from XinRay Systems Inc., a US based technology developer. These technologies enable the miniaturisation of a number of X-ray applications relevant to large global markets.
The Company has three initial products in its development pipeline – a mobile medical x-ray imager for hospitals, a version for deployed military use and a mobile security back-scatter imager. It is establishing manufacturing for these products in an ISO13485 certified facility in Tonsley, South Australia.